AstraZeneca Pharma India Limited
NSE:ASTRAZEN.NS
7972 (INR) • At close May 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 12,955.3 | 10,029.7 | 8,056 | 8,085.6 | 8,317.7 | 7,282.4 | 5,710 | 5,436.9 | 5,637.323 | 4,690.488 | 4,737.482 | 3,902.542 | 5,312.797 | 5,940.25 | 3,855.212 | 3,542.647 | 2,973.137 | 2,644.104 | 2,224.212 | 1,927.005 |
| Cost of Revenue
| 6,732.6 | 4,252.6 | 3,574.6 | 3,305.4 | 3,343.7 | 2,378.1 | 1,858.5 | 1,794 | 2,128.076 | 2,053.674 | 1,891.7 | 1,753.789 | 1,859.559 | 1,859.736 | 1,251.156 | 1,037.807 | 984.275 | 959.701 | 0 | 1,446.634 |
| Gross Profit
| 6,222.7 | 5,777.1 | 4,481.4 | 4,780.2 | 4,974 | 4,904.3 | 3,851.5 | 3,642.9 | 3,509.247 | 2,636.814 | 2,845.781 | 2,148.753 | 3,453.238 | 4,080.514 | 2,604.056 | 2,504.84 | 1,988.861 | 1,684.404 | 2,224.212 | 480.371 |
| Gross Profit Ratio
| 0.48 | 0.576 | 0.556 | 0.591 | 0.598 | 0.673 | 0.675 | 0.67 | 0.623 | 0.562 | 0.601 | 0.551 | 0.65 | 0.687 | 0.675 | 0.707 | 0.669 | 0.637 | 1 | 0.249 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 102.813 | 0 | 14.412 | 20.94 | 0 | 0 | 23.475 | 0 | 20.816 | 16.994 |
| General & Administrative Expenses
| 421.5 | 299.3 | 280 | 318.9 | 304.9 | 262.8 | 176.5 | 193.1 | 200.494 | 214.397 | 209.029 | 216.074 | 259.984 | 1,077.467 | 786.009 | 609.424 | 477.61 | 461.035 | 0 | 0 |
| Selling & Marketing Expenses
| 915.4 | 662.2 | 569.9 | 512 | 611 | 840.9 | 767.3 | 574.8 | 798.182 | 735.031 | 515.225 | 466.651 | 593.352 | 329.178 | 134.285 | 79.969 | 97.292 | 54.822 | 0 | 0 |
| SG&A
| 1,336.9 | 961.5 | 849.9 | 830.9 | 915.9 | 1,103.7 | 943.8 | 767.9 | 998.676 | 949.428 | 724.254 | 682.725 | 1,287.534 | 1,406.645 | 920.294 | 689.393 | 574.902 | 515.857 | 0 | 121.973 |
| Other Expenses
| 0 | 3,326.7 | 2,935 | 2,786.7 | 3,032.5 | 3,269.3 | 2,530.7 | 0 | 2,510.571 | 1,711.545 | 2,211.677 | 1,482.641 | 1,911.387 | 1,698.849 | 787.414 | -22.497 | 531.216 | 1,168.547 | 1,555.635 | -60.987 |
| Operating Expenses
| 4,508.4 | 4,288.2 | 3,784.9 | 3,617.6 | 3,948.4 | 4,373 | 3,474.5 | 3,415.7 | 3,509.247 | 2,660.972 | 2,935.93 | 2,165.365 | 3,213.333 | 3,126.434 | 1,707.708 | 1,302.352 | 1,129.594 | 1,684.404 | 1,576.451 | 77.981 |
| Operating Income
| 1,714.3 | 1,488.9 | 696.5 | 1,162.6 | 1,025.6 | 563.8 | 341.2 | 296.2 | -6.868 | -231.159 | -225.971 | -795.085 | 239.904 | 954.08 | 896.347 | 1,195.382 | 859.268 | 700.225 | 647.761 | 402.39 |
| Operating Income Ratio
| 0.132 | 0.148 | 0.086 | 0.144 | 0.123 | 0.077 | 0.06 | 0.054 | -0.001 | -0.049 | -0.048 | -0.204 | 0.045 | 0.161 | 0.233 | 0.337 | 0.289 | 0.265 | 0.291 | 0.209 |
| Total Other Income Expenses Net
| 481.1 | -147.9 | 133.9 | 108.3 | 114.1 | 162.9 | 96.8 | 58.8 | 64.504 | 22.762 | 218.427 | 92.385 | 52.644 | 55.384 | -12.426 | -51.622 | 94.221 | 49.286 | 0 | 34.495 |
| Income Before Tax
| 2,195.4 | 1,341 | 830.4 | 1,270.9 | 1,139.7 | 726.7 | 438 | 355 | 57.636 | -208.397 | -7.544 | -702.7 | 292.548 | 1,009.463 | 883.922 | 1,143.76 | 953.489 | 749.511 | 647.761 | 436.886 |
| Income Before Tax Ratio
| 0.169 | 0.134 | 0.103 | 0.157 | 0.137 | 0.1 | 0.077 | 0.065 | 0.01 | -0.044 | -0.002 | -0.18 | 0.055 | 0.17 | 0.229 | 0.323 | 0.321 | 0.283 | 0.291 | 0.227 |
| Income Tax Expense
| 580.3 | 348.1 | 214.4 | 337.9 | 417.6 | 182.2 | 178.9 | 154.5 | 5.047 | 0 | 5.089 | 192.623 | 94.897 | 368.166 | 307.749 | 405.408 | 338.903 | 262.149 | 217.18 | 167.145 |
| Net Income
| 1,615.1 | 992.9 | 616 | 933 | 722.1 | 544.5 | 259.1 | 200.5 | 52.59 | -208.397 | -5.089 | -895.323 | 197.651 | 641.298 | 576.172 | 738.352 | 614.586 | 487.362 | 430.581 | 257.503 |
| Net Income Ratio
| 0.125 | 0.099 | 0.076 | 0.115 | 0.087 | 0.075 | 0.045 | 0.037 | 0.009 | -0.044 | -0.001 | -0.229 | 0.037 | 0.108 | 0.149 | 0.208 | 0.207 | 0.184 | 0.194 | 0.134 |
| EPS
| 64.6 | 39.72 | 24.64 | 37.32 | 28.88 | 21.78 | 10.36 | 8 | 2.1 | -8.34 | -0.2 | -35.81 | 7.91 | 25.65 | 23.05 | 29.53 | 24.58 | 19.49 | 17.22 | 10.3 |
| EPS Diluted
| 64.6 | 39.72 | 24.64 | 37.32 | 28.88 | 21.78 | 10.36 | 8 | 2.1 | -8.34 | -0.2 | -35.81 | 7.91 | 25.65 | 23.05 | 29.53 | 24.58 | 19.49 | 17.22 | 10.3 |
| EBITDA
| 2,356.8 | 1,509.9 | 1,009.4 | 1,479.3 | 1,336.9 | 875.9 | 492.8 | 454.5 | 171.986 | -78.344 | -124.34 | -677.506 | 310.091 | 1,042.208 | 946.058 | 1,261.153 | 998.534 | 757.535 | 699.707 | 481.362 |
| EBITDA Ratio
| 0.182 | 0.151 | 0.125 | 0.183 | 0.161 | 0.12 | 0.086 | 0.084 | 0.031 | -0.017 | -0.026 | -0.174 | 0.058 | 0.175 | 0.245 | 0.356 | 0.336 | 0.286 | 0.315 | 0.25 |